Opioid Agonist class drugs

76 results
  • conzip

    (tramadol hydrochloride)
    Vertical Pharmaceuticals, LLC
    CONZIP is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not intended for as-needed use and should be reserved for patients who have not responded to non-opioid analgesics or immediate-release opioids due to risks of addiction and overdose.
  • demerol

    (MEPERIDINE HYDROCHLORIDE)
    Hospira, Inc.
    DEMEROL Injection is indicated for preoperative medication, anesthesia support, obstetrical analgesia, and managing severe pain that alternative treatments cannot adequately address. It should be reserved for patients who cannot tolerate or benefit from non-opioid options due to the risk of addiction and other complications.
  • dsuvia

    (Sufentanil)
    AcelRx Pharmaceuticals, Inc.
    DSUVIA is indicated for adult patients in certified healthcare settings to manage acute pain severe enough to require opioid analgesia when alternatives are inadequate. It is not for home use, children, or extended use beyond 72 hours, and must be administered by a healthcare provider.
  • duramorph

    (morphine sulfate)
    Hikma Pharmaceuticals USA Inc.
    DURAMORPH is indicated for managing severe pain requiring opioid analgesics via intravenous, epidural, or intrathecal administration, when alternative treatments have proven inadequate. It is not for continuous microinfusion devices and should be reserved for patients who cannot tolerate or achieve adequate relief with non-opioid options.
  • endocet

    (Oxycodone and Acetaminophen)
    ENDO USA, Inc.
    ENDOCET is indicated for managing severe pain that requires an opioid analgesic when alternative treatments are insufficient. It is reserved for patients unable to tolerate or achieve adequate relief from non-opioid options and should not be used long-term unless necessary.
  • fentanyl citrate

    (FENTANYL CITRATE)
    Hospira, Inc.
    Fentanyl Citrate Injection is indicated for short-duration analgesia during anesthesia, premedication, induction, and maintenance of anesthesia, as well as in the recovery period. It serves as an opioid supplement in general or regional anesthesia and is used in high-risk surgical patients.
  • hydrocodone bitartrate and acetaminophen

    (Hydrocodone Bitartrate and Acetaminophen)
    Amneal Pharmaceuticals LLC
    Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for managing severe pain when alternative treatments are inadequate. They are to be used cautiously due to addiction risks and should be reserved for patients who cannot tolerate or do not achieve relief from non-opioid analgesics.
  • hydrocodone bitartrate and acetaminophen

    (Hydrocodone Bitartrate and Acetaminophen)
    Amneal Pharmaceuticals of New York LLC
    Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for managing severe pain when alternative treatments are insufficient. Due to the risk of addiction and misuse, they should be reserved for patients not responding to or unable to tolerate non-opioid analgesics. Long-term use is not recommended.
  • hydrocodone bitartrate and acetaminophen

    (Hydrocodone Bitartrate and Acetaminophen)
    Tris Pharma Inc
    Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for managing severe pain when alternative treatments are inadequate. They should be used cautiously due to risks of addiction, abuse, and misuse, and are not intended for prolonged use unless absolutely necessary.
  • hydrocodone bitartrate and acetaminophen

    (Hydrocodone Bitartrate and Acetaminophen)
    SpecGx LLC
    Hydrocodone bitartrate and acetaminophen tablets are indicated for managing severe pain requiring opioid analgesics when alternative treatments are inadequate. Use is limited due to risks of addiction and misuse, recommended only when non-opioid options are ineffective or intolerable, and should not be prolonged unnecessarily.